Natco Pharma Limited | NATCOPHARM | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
8,247
5,687
5,796
2,022
8,619
Cash flow Operating Act...
Cash flow Operating Activities
6,6884,1732,9884658,491
Investments in PPE
Investments in PPE
-4,566-3,558-2,546-2,328-1,463
Cash flow Investing Act...
Net cash used for Investment Activities
-6,122-1,670-1,033-53-4,771
Dividend Paid
Dividend Paid
1,1061,5361,1398221,004
Cash flow Financing Act...
Net cash provided by Financing Activities
-509-2,508-1,857348-3,630
Cash at beginning of period
Cash at beginning of period
2172831982581,111
Cash at end of period
Cash at end of period
2831982581,1111,319
Free Cash Flow
Free Cash Flow
2,122
615
442
-1,863
7,028